[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biological Hemostatic Material Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

March 2023 | 113 pages | ID: GD25E59C1EC5EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Biological Hemostatic Material market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Biological hemostatic agents are active agents that work to provide hemostasis by activating clotting factors in the final stages of the coagulation cascade. Thrombin is activated by calcium and as noted previously acts to convert fibrinogen to fibrin, stabilizing the clot.

This report is a detailed and comprehensive analysis for global Biological Hemostatic Material market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Biological Hemostatic Material market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Biological Hemostatic Material market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Biological Hemostatic Material market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Biological Hemostatic Material market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Biological Hemostatic Material

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Biological Hemostatic Material market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, BD, Baxter, B.Braun and Cura Medical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Biological Hemostatic Material market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Collagen
  • Gelatin
  • Polysaccharides
  • Other
Market segment by Application
  • Hospital
  • Clinic
  • Other
Major players covered
  • Johnson & Johnson
  • BD
  • Baxter
  • B.Braun
  • Cura Medical
  • GELITA MEDICAL
  • Curasan AG
  • Meril Life Sciences
  • Zhonghui Shengxi
  • Beijing Datsing Bio-tech
  • Guizhou Jin Jiu Biotech
  • Beijing Taikesiman
  • Foryou Medical
  • Saikesaisi Holdings Group
  • Biotemed
  • Hangzhou Singclean Medical Products
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Biological Hemostatic Material product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Biological Hemostatic Material, with price, sales, revenue and global market share of Biological Hemostatic Material from 2018 to 2023.

Chapter 3, the Biological Hemostatic Material competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Biological Hemostatic Material breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Biological Hemostatic Material market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Biological Hemostatic Material.

Chapter 14 and 15, to describe Biological Hemostatic Material sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Biological Hemostatic Material
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Biological Hemostatic Material Consumption Value by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Collagen
  1.3.3 Gelatin
  1.3.4 Polysaccharides
  1.3.5 Other
1.4 Market Analysis by Application
  1.4.1 Overview: Global Biological Hemostatic Material Consumption Value by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Hospital
  1.4.3 Clinic
  1.4.4 Other
1.5 Global Biological Hemostatic Material Market Size & Forecast
  1.5.1 Global Biological Hemostatic Material Consumption Value (2018 & 2022 & 2029)
  1.5.2 Global Biological Hemostatic Material Sales Quantity (2018-2029)
  1.5.3 Global Biological Hemostatic Material Average Price (2018-2029)

2 MANUFACTURERS PROFILES

2.1 Johnson & Johnson
  2.1.1 Johnson & Johnson Details
  2.1.2 Johnson & Johnson Major Business
  2.1.3 Johnson & Johnson Biological Hemostatic Material Product and Services
  2.1.4 Johnson & Johnson Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Johnson & Johnson Recent Developments/Updates
2.2 BD
  2.2.1 BD Details
  2.2.2 BD Major Business
  2.2.3 BD Biological Hemostatic Material Product and Services
  2.2.4 BD Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 BD Recent Developments/Updates
2.3 Baxter
  2.3.1 Baxter Details
  2.3.2 Baxter Major Business
  2.3.3 Baxter Biological Hemostatic Material Product and Services
  2.3.4 Baxter Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Baxter Recent Developments/Updates
2.4 B.Braun
  2.4.1 B.Braun Details
  2.4.2 B.Braun Major Business
  2.4.3 B.Braun Biological Hemostatic Material Product and Services
  2.4.4 B.Braun Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 B.Braun Recent Developments/Updates
2.5 Cura Medical
  2.5.1 Cura Medical Details
  2.5.2 Cura Medical Major Business
  2.5.3 Cura Medical Biological Hemostatic Material Product and Services
  2.5.4 Cura Medical Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Cura Medical Recent Developments/Updates
2.6 GELITA MEDICAL
  2.6.1 GELITA MEDICAL Details
  2.6.2 GELITA MEDICAL Major Business
  2.6.3 GELITA MEDICAL Biological Hemostatic Material Product and Services
  2.6.4 GELITA MEDICAL Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 GELITA MEDICAL Recent Developments/Updates
2.7 Curasan AG
  2.7.1 Curasan AG Details
  2.7.2 Curasan AG Major Business
  2.7.3 Curasan AG Biological Hemostatic Material Product and Services
  2.7.4 Curasan AG Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 Curasan AG Recent Developments/Updates
2.8 Meril Life Sciences
  2.8.1 Meril Life Sciences Details
  2.8.2 Meril Life Sciences Major Business
  2.8.3 Meril Life Sciences Biological Hemostatic Material Product and Services
  2.8.4 Meril Life Sciences Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 Meril Life Sciences Recent Developments/Updates
2.9 Zhonghui Shengxi
  2.9.1 Zhonghui Shengxi Details
  2.9.2 Zhonghui Shengxi Major Business
  2.9.3 Zhonghui Shengxi Biological Hemostatic Material Product and Services
  2.9.4 Zhonghui Shengxi Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Zhonghui Shengxi Recent Developments/Updates
2.10 Beijing Datsing Bio-tech
  2.10.1 Beijing Datsing Bio-tech Details
  2.10.2 Beijing Datsing Bio-tech Major Business
  2.10.3 Beijing Datsing Bio-tech Biological Hemostatic Material Product and Services
  2.10.4 Beijing Datsing Bio-tech Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 Beijing Datsing Bio-tech Recent Developments/Updates
2.11 Guizhou Jin Jiu Biotech
  2.11.1 Guizhou Jin Jiu Biotech Details
  2.11.2 Guizhou Jin Jiu Biotech Major Business
  2.11.3 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product and Services
  2.11.4 Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.11.5 Guizhou Jin Jiu Biotech Recent Developments/Updates
2.12 Beijing Taikesiman
  2.12.1 Beijing Taikesiman Details
  2.12.2 Beijing Taikesiman Major Business
  2.12.3 Beijing Taikesiman Biological Hemostatic Material Product and Services
  2.12.4 Beijing Taikesiman Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.12.5 Beijing Taikesiman Recent Developments/Updates
2.13 Foryou Medical
  2.13.1 Foryou Medical Details
  2.13.2 Foryou Medical Major Business
  2.13.3 Foryou Medical Biological Hemostatic Material Product and Services
  2.13.4 Foryou Medical Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.13.5 Foryou Medical Recent Developments/Updates
2.14 Saikesaisi Holdings Group
  2.14.1 Saikesaisi Holdings Group Details
  2.14.2 Saikesaisi Holdings Group Major Business
  2.14.3 Saikesaisi Holdings Group Biological Hemostatic Material Product and Services
  2.14.4 Saikesaisi Holdings Group Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.14.5 Saikesaisi Holdings Group Recent Developments/Updates
2.15 Biotemed
  2.15.1 Biotemed Details
  2.15.2 Biotemed Major Business
  2.15.3 Biotemed Biological Hemostatic Material Product and Services
  2.15.4 Biotemed Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.15.5 Biotemed Recent Developments/Updates
2.16 Hangzhou Singclean Medical Products
  2.16.1 Hangzhou Singclean Medical Products Details
  2.16.2 Hangzhou Singclean Medical Products Major Business
  2.16.3 Hangzhou Singclean Medical Products Biological Hemostatic Material Product and Services
  2.16.4 Hangzhou Singclean Medical Products Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.16.5 Hangzhou Singclean Medical Products Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: BIOLOGICAL HEMOSTATIC MATERIAL BY MANUFACTURER

3.1 Global Biological Hemostatic Material Sales Quantity by Manufacturer (2018-2023)
3.2 Global Biological Hemostatic Material Revenue by Manufacturer (2018-2023)
3.3 Global Biological Hemostatic Material Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
  3.4.1 Producer Shipments of Biological Hemostatic Material by Manufacturer Revenue ($MM) and Market Share (%): 2022
  3.4.2 Top 3 Biological Hemostatic Material Manufacturer Market Share in 2022
  3.4.2 Top 6 Biological Hemostatic Material Manufacturer Market Share in 2022
3.5 Biological Hemostatic Material Market: Overall Company Footprint Analysis
  3.5.1 Biological Hemostatic Material Market: Region Footprint
  3.5.2 Biological Hemostatic Material Market: Company Product Type Footprint
  3.5.3 Biological Hemostatic Material Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Biological Hemostatic Material Market Size by Region
  4.1.1 Global Biological Hemostatic Material Sales Quantity by Region (2018-2029)
  4.1.2 Global Biological Hemostatic Material Consumption Value by Region (2018-2029)
  4.1.3 Global Biological Hemostatic Material Average Price by Region (2018-2029)
4.2 North America Biological Hemostatic Material Consumption Value (2018-2029)
4.3 Europe Biological Hemostatic Material Consumption Value (2018-2029)
4.4 Asia-Pacific Biological Hemostatic Material Consumption Value (2018-2029)
4.5 South America Biological Hemostatic Material Consumption Value (2018-2029)
4.6 Middle East and Africa Biological Hemostatic Material Consumption Value (2018-2029)

5 MARKET SEGMENT BY TYPE

5.1 Global Biological Hemostatic Material Sales Quantity by Type (2018-2029)
5.2 Global Biological Hemostatic Material Consumption Value by Type (2018-2029)
5.3 Global Biological Hemostatic Material Average Price by Type (2018-2029)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Biological Hemostatic Material Sales Quantity by Application (2018-2029)
6.2 Global Biological Hemostatic Material Consumption Value by Application (2018-2029)
6.3 Global Biological Hemostatic Material Average Price by Application (2018-2029)

7 NORTH AMERICA

7.1 North America Biological Hemostatic Material Sales Quantity by Type (2018-2029)
7.2 North America Biological Hemostatic Material Sales Quantity by Application (2018-2029)
7.3 North America Biological Hemostatic Material Market Size by Country
  7.3.1 North America Biological Hemostatic Material Sales Quantity by Country (2018-2029)
  7.3.2 North America Biological Hemostatic Material Consumption Value by Country (2018-2029)
  7.3.3 United States Market Size and Forecast (2018-2029)
  7.3.4 Canada Market Size and Forecast (2018-2029)
  7.3.5 Mexico Market Size and Forecast (2018-2029)

8 EUROPE

8.1 Europe Biological Hemostatic Material Sales Quantity by Type (2018-2029)
8.2 Europe Biological Hemostatic Material Sales Quantity by Application (2018-2029)
8.3 Europe Biological Hemostatic Material Market Size by Country
  8.3.1 Europe Biological Hemostatic Material Sales Quantity by Country (2018-2029)
  8.3.2 Europe Biological Hemostatic Material Consumption Value by Country (2018-2029)
  8.3.3 Germany Market Size and Forecast (2018-2029)
  8.3.4 France Market Size and Forecast (2018-2029)
  8.3.5 United Kingdom Market Size and Forecast (2018-2029)
  8.3.6 Russia Market Size and Forecast (2018-2029)
  8.3.7 Italy Market Size and Forecast (2018-2029)

9 ASIA-PACIFIC

9.1 Asia-Pacific Biological Hemostatic Material Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Biological Hemostatic Material Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Biological Hemostatic Material Market Size by Region
  9.3.1 Asia-Pacific Biological Hemostatic Material Sales Quantity by Region (2018-2029)
  9.3.2 Asia-Pacific Biological Hemostatic Material Consumption Value by Region (2018-2029)
  9.3.3 China Market Size and Forecast (2018-2029)
  9.3.4 Japan Market Size and Forecast (2018-2029)
  9.3.5 Korea Market Size and Forecast (2018-2029)
  9.3.6 India Market Size and Forecast (2018-2029)
  9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
  9.3.8 Australia Market Size and Forecast (2018-2029)

10 SOUTH AMERICA

10.1 South America Biological Hemostatic Material Sales Quantity by Type (2018-2029)
10.2 South America Biological Hemostatic Material Sales Quantity by Application (2018-2029)
10.3 South America Biological Hemostatic Material Market Size by Country
  10.3.1 South America Biological Hemostatic Material Sales Quantity by Country (2018-2029)
  10.3.2 South America Biological Hemostatic Material Consumption Value by Country (2018-2029)
  10.3.3 Brazil Market Size and Forecast (2018-2029)
  10.3.4 Argentina Market Size and Forecast (2018-2029)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Biological Hemostatic Material Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Biological Hemostatic Material Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Biological Hemostatic Material Market Size by Country
  11.3.1 Middle East & Africa Biological Hemostatic Material Sales Quantity by Country (2018-2029)
  11.3.2 Middle East & Africa Biological Hemostatic Material Consumption Value by Country (2018-2029)
  11.3.3 Turkey Market Size and Forecast (2018-2029)
  11.3.4 Egypt Market Size and Forecast (2018-2029)
  11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
  11.3.6 South Africa Market Size and Forecast (2018-2029)

12 MARKET DYNAMICS

12.1 Biological Hemostatic Material Market Drivers
12.2 Biological Hemostatic Material Market Restraints
12.3 Biological Hemostatic Material Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
  12.5.1 Influence of COVID-19
  12.5.2 Influence of Russia-Ukraine War

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Biological Hemostatic Material and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biological Hemostatic Material
13.3 Biological Hemostatic Material Production Process
13.4 Biological Hemostatic Material Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Biological Hemostatic Material Typical Distributors
14.3 Biological Hemostatic Material Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Biological Hemostatic Material Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biological Hemostatic Material Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Biological Hemostatic Material Product and Services
Table 6. Johnson & Johnson Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Johnson & Johnson Recent Developments/Updates
Table 8. BD Basic Information, Manufacturing Base and Competitors
Table 9. BD Major Business
Table 10. BD Biological Hemostatic Material Product and Services
Table 11. BD Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. BD Recent Developments/Updates
Table 13. Baxter Basic Information, Manufacturing Base and Competitors
Table 14. Baxter Major Business
Table 15. Baxter Biological Hemostatic Material Product and Services
Table 16. Baxter Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Baxter Recent Developments/Updates
Table 18. B.Braun Basic Information, Manufacturing Base and Competitors
Table 19. B.Braun Major Business
Table 20. B.Braun Biological Hemostatic Material Product and Services
Table 21. B.Braun Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. B.Braun Recent Developments/Updates
Table 23. Cura Medical Basic Information, Manufacturing Base and Competitors
Table 24. Cura Medical Major Business
Table 25. Cura Medical Biological Hemostatic Material Product and Services
Table 26. Cura Medical Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Cura Medical Recent Developments/Updates
Table 28. GELITA MEDICAL Basic Information, Manufacturing Base and Competitors
Table 29. GELITA MEDICAL Major Business
Table 30. GELITA MEDICAL Biological Hemostatic Material Product and Services
Table 31. GELITA MEDICAL Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. GELITA MEDICAL Recent Developments/Updates
Table 33. Curasan AG Basic Information, Manufacturing Base and Competitors
Table 34. Curasan AG Major Business
Table 35. Curasan AG Biological Hemostatic Material Product and Services
Table 36. Curasan AG Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Curasan AG Recent Developments/Updates
Table 38. Meril Life Sciences Basic Information, Manufacturing Base and Competitors
Table 39. Meril Life Sciences Major Business
Table 40. Meril Life Sciences Biological Hemostatic Material Product and Services
Table 41. Meril Life Sciences Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Meril Life Sciences Recent Developments/Updates
Table 43. Zhonghui Shengxi Basic Information, Manufacturing Base and Competitors
Table 44. Zhonghui Shengxi Major Business
Table 45. Zhonghui Shengxi Biological Hemostatic Material Product and Services
Table 46. Zhonghui Shengxi Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Zhonghui Shengxi Recent Developments/Updates
Table 48. Beijing Datsing Bio-tech Basic Information, Manufacturing Base and Competitors
Table 49. Beijing Datsing Bio-tech Major Business
Table 50. Beijing Datsing Bio-tech Biological Hemostatic Material Product and Services
Table 51. Beijing Datsing Bio-tech Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Beijing Datsing Bio-tech Recent Developments/Updates
Table 53. Guizhou Jin Jiu Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Guizhou Jin Jiu Biotech Major Business
Table 55. Guizhou Jin Jiu Biotech Biological Hemostatic Material Product and Services
Table 56. Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Guizhou Jin Jiu Biotech Recent Developments/Updates
Table 58. Beijing Taikesiman Basic Information, Manufacturing Base and Competitors
Table 59. Beijing Taikesiman Major Business
Table 60. Beijing Taikesiman Biological Hemostatic Material Product and Services
Table 61. Beijing Taikesiman Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Beijing Taikesiman Recent Developments/Updates
Table 63. Foryou Medical Basic Information, Manufacturing Base and Competitors
Table 64. Foryou Medical Major Business
Table 65. Foryou Medical Biological Hemostatic Material Product and Services
Table 66. Foryou Medical Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Foryou Medical Recent Developments/Updates
Table 68. Saikesaisi Holdings Group Basic Information, Manufacturing Base and Competitors
Table 69. Saikesaisi Holdings Group Major Business
Table 70. Saikesaisi Holdings Group Biological Hemostatic Material Product and Services
Table 71. Saikesaisi Holdings Group Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Saikesaisi Holdings Group Recent Developments/Updates
Table 73. Biotemed Basic Information, Manufacturing Base and Competitors
Table 74. Biotemed Major Business
Table 75. Biotemed Biological Hemostatic Material Product and Services
Table 76. Biotemed Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Biotemed Recent Developments/Updates
Table 78. Hangzhou Singclean Medical Products Basic Information, Manufacturing Base and Competitors
Table 79. Hangzhou Singclean Medical Products Major Business
Table 80. Hangzhou Singclean Medical Products Biological Hemostatic Material Product and Services
Table 81. Hangzhou Singclean Medical Products Biological Hemostatic Material Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Hangzhou Singclean Medical Products Recent Developments/Updates
Table 83. Global Biological Hemostatic Material Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 84. Global Biological Hemostatic Material Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Biological Hemostatic Material Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 86. Market Position of Manufacturers in Biological Hemostatic Material, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Biological Hemostatic Material Production Site of Key Manufacturer
Table 88. Biological Hemostatic Material Market: Company Product Type Footprint
Table 89. Biological Hemostatic Material Market: Company Product Application Footprint
Table 90. Biological Hemostatic Material New Market Entrants and Barriers to Market Entry
Table 91. Biological Hemostatic Material Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Biological Hemostatic Material Sales Quantity by Region (2018-2023) & (K Units)
Table 93. Global Biological Hemostatic Material Sales Quantity by Region (2024-2029) & (K Units)
Table 94. Global Biological Hemostatic Material Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Biological Hemostatic Material Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Biological Hemostatic Material Average Price by Region (2018-2023) & (US$/Unit)
Table 97. Global Biological Hemostatic Material Average Price by Region (2024-2029) & (US$/Unit)
Table 98. Global Biological Hemostatic Material Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Global Biological Hemostatic Material Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Global Biological Hemostatic Material Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Biological Hemostatic Material Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Biological Hemostatic Material Average Price by Type (2018-2023) & (US$/Unit)
Table 103. Global Biological Hemostatic Material Average Price by Type (2024-2029) & (US$/Unit)
Table 104. Global Biological Hemostatic Material Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Global Biological Hemostatic Material Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Global Biological Hemostatic Material Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Biological Hemostatic Material Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Biological Hemostatic Material Average Price by Application (2018-2023) & (US$/Unit)
Table 109. Global Biological Hemostatic Material Average Price by Application (2024-2029) & (US$/Unit)
Table 110. North America Biological Hemostatic Material Sales Quantity by Type (2018-2023) & (K Units)
Table 111. North America Biological Hemostatic Material Sales Quantity by Type (2024-2029) & (K Units)
Table 112. North America Biological Hemostatic Material Sales Quantity by Application (2018-2023) & (K Units)
Table 113. North America Biological Hemostatic Material Sales Quantity by Application (2024-2029) & (K Units)
Table 114. North America Biological Hemostatic Material Sales Quantity by Country (2018-2023) & (K Units)
Table 115. North America Biological Hemostatic Material Sales Quantity by Country (2024-2029) & (K Units)
Table 116. North America Biological Hemostatic Material Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Biological Hemostatic Material Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Biological Hemostatic Material Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Europe Biological Hemostatic Material Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Europe Biological Hemostatic Material Sales Quantity by Application (2018-2023) & (K Units)
Table 121. Europe Biological Hemostatic Material Sales Quantity by Application (2024-2029) & (K Units)
Table 122. Europe Biological Hemostatic Material Sales Quantity by Country (2018-2023) & (K Units)
Table 123. Europe Biological Hemostatic Material Sales Quantity by Country (2024-2029) & (K Units)
Table 124. Europe Biological Hemostatic Material Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Biological Hemostatic Material Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Biological Hemostatic Material Sales Quantity by Type (2018-2023) & (K Units)
Table 127. Asia-Pacific Biological Hemostatic Material Sales Quantity by Type (2024-2029) & (K Units)
Table 128. Asia-Pacific Biological Hemostatic Material Sales Quantity by Application (2018-2023) & (K Units)
Table 129. Asia-Pacific Biological Hemostatic Material Sales Quantity by Application (2024-2029) & (K Units)
Table 130. Asia-Pacific Biological Hemostatic Material Sales Quantity by Region (2018-2023) & (K Units)
Table 131. Asia-Pacific Biological Hemostatic Material Sales Quantity by Region (2024-2029) & (K Units)
Table 132. Asia-Pacific Biological Hemostatic Material Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Biological Hemostatic Material Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Biological Hemostatic Material Sales Quantity by Type (2018-2023) & (K Units)
Table 135. South America Biological Hemostatic Material Sales Quantity by Type (2024-2029) & (K Units)
Table 136. South America Biological Hemostatic Material Sales Quantity by Application (2018-2023) & (K Units)
Table 137. South America Biological Hemostatic Material Sales Quantity by Application (2024-2029) & (K Units)
Table 138. South America Biological Hemostatic Material Sales Quantity by Country (2018-2023) & (K Units)
Table 139. South America Biological Hemostatic Material Sales Quantity by Country (2024-2029) & (K Units)
Table 140. South America Biological Hemostatic Material Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Biological Hemostatic Material Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Biological Hemostatic Material Sales Quantity by Type (2018-2023) & (K Units)
Table 143. Middle East & Africa Biological Hemostatic Material Sales Quantity by Type (2024-2029) & (K Units)
Table 144. Middle East & Africa Biological Hemostatic Material Sales Quantity by Application (2018-2023) & (K Units)
Table 145. Middle East & Africa Biological Hemostatic Material Sales Quantity by Application (2024-2029) & (K Units)
Table 146. Middle East & Africa Biological Hemostatic Material Sales Quantity by Region (2018-2023) & (K Units)
Table 147. Middle East & Africa Biological Hemostatic Material Sales Quantity by Region (2024-2029) & (K Units)
Table 148. Middle East & Africa Biological Hemostatic Material Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Biological Hemostatic Material Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Biological Hemostatic Material Raw Material
Table 151. Key Manufacturers of Biological Hemostatic Material Raw Materials
Table 152. Biological Hemostatic Material Typical Distributors
Table 153. Biological Hemostatic Material Typical Customers

LIST OF FIGURES

Figure 1. Biological Hemostatic Material Picture
Figure 2. Global Biological Hemostatic Material Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biological Hemostatic Material Consumption Value Market Share by Type in 2022
Figure 4. Collagen Examples
Figure 5. Gelatin Examples
Figure 6. Polysaccharides Examples
Figure 7. Other Examples
Figure 8. Global Biological Hemostatic Material Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Biological Hemostatic Material Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Other Examples
Figure 13. Global Biological Hemostatic Material Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Biological Hemostatic Material Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Biological Hemostatic Material Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Biological Hemostatic Material Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Biological Hemostatic Material Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Biological Hemostatic Material Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Biological Hemostatic Material by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Biological Hemostatic Material Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Biological Hemostatic Material Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Biological Hemostatic Material Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Biological Hemostatic Material Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Biological Hemostatic Material Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Biological Hemostatic Material Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Biological Hemostatic Material Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Biological Hemostatic Material Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Biological Hemostatic Material Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Biological Hemostatic Material Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Biological Hemostatic Material Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Biological Hemostatic Material Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Biological Hemostatic Material Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Biological Hemostatic Material Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Biological Hemostatic Material Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Biological Hemostatic Material Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Biological Hemostatic Material Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Biological Hemostatic Material Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Biological Hemostatic Material Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Biological Hemostatic Material Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Biological Hemostatic Material Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Biological Hemostatic Material Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Biological Hemostatic Material Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Biological Hemostatic Material Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Biological Hemostatic Material Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Biological Hemostatic Material Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Biological Hemostatic Material Consumption Value Market Share by Region (2018-2029)
Figure 55. China Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Biological Hemostatic Material Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Biological Hemostatic Material Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Biological Hemostatic Material Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Biological Hemostatic Material Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Biological Hemostatic Material Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Biological Hemostatic Material Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Biological Hemostatic Material Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Biological Hemostatic Material Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Biological Hemostatic Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Biological Hemostatic Material Market Drivers
Figure 76. Biological Hemostatic Material Market Restraints
Figure 77. Biological Hemostatic Material Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Biological Hemostatic Material in 2022
Figure 80. Manufacturing Process Analysis of Biological Hemostatic Material
Figure 81. Biological Hemostatic Material Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source


More Publications